MiR-216a and miR-216b as markers for acute phased pancreatic injury

Biomedical Research (Japan)

Volumn 34, Issue 4, 2013, Pages 179-188

  Endo, Kosuke ^a   Weng, Huachun ^a   Kito, Naoko ^a   Fukushima, Yasue ^a   Iwa, Naoharu ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 216A; MICRORNA 216B; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE MODEL; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; NONHUMAN; PANCREAS ISLET; PROTEIN EXPRESSION; RAT; TISSUE SPECIFICITY;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; ORGAN SPECIFICITY; PANCREATITIS; RATS; REPRODUCIBILITY OF RESULTS;

EID: 84883419512     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.179     Document Type: Article

References (44)

1. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H and Iwai N (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56, 1183-1185.
2. Ambros V (2001) microRNAs: tiny regulators with great potential. Cell 107, 823-826.
3. Argyropoulos C, Wang K, McClarty S, Huang D, Bernardo J, Ellis D, Orchard T, Galas D and Johnson J (2013) Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One 8, e54662.
4. Baek D, Villen J, Shin C, Camargo FD, Gygi SP and Bartel DP (2008) The impact of microRNAs on protein output. Nature 455, 64-71.
5. Bagnall RD, Tsoutsman T, Shephard RE, Ritchie W and Semsarian C (2012) Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure. PLoS One 7, e44744
6. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zöllner H, Schmiegel W, Hahn S and Schroers R (2012) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncol 14, 29-33.
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
8. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, Kuslich C, Visakorpi T and Hamdy FC (2012) Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 106, 768-774.
9. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN and Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6, e23937.
10. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ and Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, e179.
11. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J and Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006.
12. Croce CM (2008) Oncogenes and cancer. New Engl J Med 358, 502-511.
13. Endo K, Naito Y, Ji X, Nakanishi M, Noguchi T, Goto Y, Nonogi H, Ma X, Weng H, Hirokawa G, Asada T, Kakinoki S, Yamaoka T, Fukushima Y and Iwai N (2013) MicroRNA 210 as a biomarker for congestive heart failure. Biol Pharm Bull 36, 48-54.
14. Erener S, Mojibian M, Fox JK, Denroche HC and Kieffer TJ (2013) Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology 154, 603-608.
15. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S and Monia BP (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98.
16. Fichtlscherer S, Zeiher AM and Dimmeler S (2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31, 2383-2390.
17. Friedman RC, Farh KK, Burge CB and Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105.
18. Fukushima Y, Nakanishi M, Nonogi H, Goto Y and Iwai N (2011) Assessment of plasma miRNAs in congestive heart failure. Circ J 75, 336-340.
19. Ghidoni R, Benussi L, Paterlini A, Albertini V, Binetti G and Emanuele E (2011) Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future. Neurodegener Dis 8, 413-420.
20. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y and Chajut A (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148.
21. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF and Yang MY (2012) Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 33, 1933- 1942.
22. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D and Marsh CB (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694.
23. Ji X, Naito Y, Weng H, Endo K, Ma X and Iwai N (2012) P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension. Am J Physiol Renal Physiol 303, F1207-1215.
24. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N. (2009) Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55, 1944-1949.
25. Jonsdottir K, Janssen SR, Da Rosa FC, Gudlaugsson E, Skaland I, Baak JP and Janssen EA (2012) Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers. PLoS One 7, e48692.
26. Jopling C (2012) Liver-specific microRNA-122: Biogenesis and function. RNA Biol 9, 137-142.
27. Kajimoto K, Naraba H and Iwai N (2006) MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA 12, 1626-1632.
28. Kong X, Du Y, Li L, Liu J, Wang G, Zhu J, Man X, Gong Y, Xiao L, Zheng Y, Deng S, Gu J and Li Z (2010) Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis. World J Gastroenterol 16, 4599- 4604.
29. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12, 735-739.
30. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD and Glaab WE (2009) Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55, 1977- 1983.
31. Lewis BP, Burge CB and Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
32. Lerch MM and Gorelick FS (2013) Models of acute and chronic pancreatitis. Gastroenterology 144, 1180-1193.
33. Meyerholz DK and Samuel I (2007) Morphologic characterization of early ligation-induced acute pancreatitis in rats. Am J Surg 194, 652-658.
34. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513-10518.
35. Miura K, Miura S, Yamasaki K, Higashijima A, Kinoshita A, Yoshiura K and Masuzaki H (2010) Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 56, 1767-1771.
36. Oliveira-Carvalho V, Silva MM, Guimarães GV, Bacal F and Bocchi EA (2012) MicroRNAs: new players in heart failure. Mol Biol Rep [Epub ahead of print]
37. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R and Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
38. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE and Pinto YM, (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106, 1035- 1039.
39. van de Bunt M, Gaulton KJ, Parts L, Moran I, Johnson PR, Lindgren CM, Ferrer J, Gloyn AL and McCarthy MI (2013) The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One 8, e55272.
40. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE and Galas DJ (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106, 4402-4407.
41. Weng H, Ji X, Naito Y, Endo K, Ma X, Takahashi R, Shen C, Hirokawa G, Fukushima Y and Iwai N (2013) Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. Am J Physiol Endocrinol Metab 304, E187-196.
42. Weng H, Shen C, Hirokawa G, Ji X, Takahashi R, Shimada K, Kishimoto C and Iwai N (2011) Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res 32, 135-141.
43. Yasui N, Kajimoto K, Sumiya T, Okuda T and Iwai N (2007) The monocyte chemotactic protein-1 gene may contribute to hypertension in Dahl salt-sensitive rats. Hypertens Res 30, 185-193.
44. Yin H, Pasut A, Soleimani VD, Bentzinger CF, Antoun G, Thorn S, Seale P, Fernando P, van Ijcken W, Grosveld F, Dekemp RA, Boushel R, Harper ME and Rudnicki MA (2013) MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab 17, 210-224.